BAX and urinary bladder cancer: Bax, an important homolog of Bcl-2, is a promoter of cell apoptosis and serves as an independent parameter to envisage clinical outcome for patients with bladder cancer (Golestani Eimani et al., 2014; Liu et al., 2016).